1. Home
  2. MPTI vs MCRB Comparison

MPTI vs MCRB Comparison

Compare MPTI & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MPTI
  • MCRB
  • Stock Information
  • Founded
  • MPTI 1965
  • MCRB 2010
  • Country
  • MPTI United States
  • MCRB United States
  • Employees
  • MPTI N/A
  • MCRB N/A
  • Industry
  • MPTI
  • MCRB Biotechnology: Pharmaceutical Preparations
  • Sector
  • MPTI
  • MCRB Health Care
  • Exchange
  • MPTI Nasdaq
  • MCRB Nasdaq
  • Market Cap
  • MPTI 127.2M
  • MCRB 125.7M
  • IPO Year
  • MPTI N/A
  • MCRB 2015
  • Fundamental
  • Price
  • MPTI $44.76
  • MCRB $19.44
  • Analyst Decision
  • MPTI
  • MCRB Hold
  • Analyst Count
  • MPTI 0
  • MCRB 4
  • Target Price
  • MPTI N/A
  • MCRB $73.67
  • AVG Volume (30 Days)
  • MPTI 48.3K
  • MCRB 126.4K
  • Earning Date
  • MPTI 08-12-2025
  • MCRB 08-06-2025
  • Dividend Yield
  • MPTI N/A
  • MCRB N/A
  • EPS Growth
  • MPTI 45.88
  • MCRB N/A
  • EPS
  • MPTI 2.57
  • MCRB 10.22
  • Revenue
  • MPTI $52,033,000.00
  • MCRB N/A
  • Revenue This Year
  • MPTI $11.13
  • MCRB N/A
  • Revenue Next Year
  • MPTI $8.24
  • MCRB N/A
  • P/E Ratio
  • MPTI $17.46
  • MCRB $1.98
  • Revenue Growth
  • MPTI 16.52
  • MCRB N/A
  • 52 Week Low
  • MPTI $27.50
  • MCRB $6.53
  • 52 Week High
  • MPTI $60.00
  • MCRB $26.40
  • Technical
  • Relative Strength Index (RSI)
  • MPTI 54.87
  • MCRB 69.44
  • Support Level
  • MPTI $41.00
  • MCRB $15.79
  • Resistance Level
  • MPTI $43.47
  • MCRB $18.12
  • Average True Range (ATR)
  • MPTI 1.86
  • MCRB 1.51
  • MACD
  • MPTI -0.04
  • MCRB 0.28
  • Stochastic Oscillator
  • MPTI 65.14
  • MCRB 97.69

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: